No abstract

No abstract

Background and Aim. Endoscopic stenting is a generally safe and effective palliative treatment for esophageal malignancies. In this study, we aimed to present endoscopic stent applications, adverse events, and relative advantages of covered versus uncovered stents in our center. Methods. We examined cases of endoscopic stenting for palliative treatment of advanced stage esophageal cancers between January 2014 and July 2019. Age, gender, location of mass, adverse events, survival time, and stent type were evaluated. Outcomes of fully covered and uncovered self-expanding stents were compared with regard to adverse events, including stent migration and occlusion. Results. The mean age of the patients was 66.4 ± 1 , 52 were male, and 8 were female. Patients were followed up for a mean of 133 days. The most common complication due to stenting was migration. 13 patients developed adverse events. Migration was the most common adverse event, occurring in 8 (13%) patients. Although the migration rate of fully covered stents was higher than uncovered stents, there was no statistically significant difference ( p = 0.47 ). Stent occlusion was observed in 4 patients. In three cases, it was due to the tumor; an uncovered stent was placed again in these cases. Food-related occlusion developed in one patient. There was no statistical difference in terms of overall adverse event rate when comparing fully covered stents to uncovered stents ( p = 0.68 ). Conclusion. Endoscopic stenting is a viable palliative method with low morbidity and mortality in experienced centers. Though there are relative advantages with covered versus uncovered stents in individual cases, the overall adverse event rate is low and relatively similar.

The term, Chiari Malformations, has been used to define conditions with ectopia of cerebellar tonsils below the level of the posterior edge of the foramen magnum for several decades. There are 4 traditional types based on the degree of herniation. Since the late 1990s, a group of patients with tonsillar herniation seen in Chiari type I malformation but with the addition of an elongated brainstem and fourth ventricle have been referred as Chiari type 1.5 syndromes. There are only few reports that review their treatment options and give postoperative results for this group of patients. We report a case of 49-year-old woman with Chiari type 1.5 syndrome and reviewed the literature to determine the differences between the treatment options of Chiari type 1-related and 1.5-related syringomyelia. Syringosubarachnoidal shunting must be considered as a complementary treatment option for progressive worsened, symptomatic patients with Chiari 1.5 malformation-related syringomyelia in early stages.

Background Hemorrhoidal disease is a common benign anorectal disease. Acute thrombosis that occurs during the course of hemorrhoidal disease is a painful complication. Factors affecting its etiopathogenesis are not known definitively. The aim of this study, therefore, was to assess predisposition to coagulation during the development of the disease. Method 30 patients with acute thrombosed hemorrhoidal disease and 30 other patients with hemorrhoidal disease but no thromboses were included in the study. Samples collected from these patients were analyzed with thromboelastography machines. The results were compared with patients’ demographic data. Results No statistically significant difference was found between the groups as per age, sex, diarrhea, history of a similar attack, history of surgical treatment, spicy food consumption, fibrous food consumption, and regular exercise. The results of our study revealed that the alpha angle was smaller in patients with acute thrombosed hemorrhoidal disease. Conclusion Hypercoagulability does not occur in patients with acute thrombosed hemorrhoidal disease